This study investigates differences in treatment outcomes for patients with prostate cancer. Information from this study may help researchers develop a way to better identify the best treatment options for patients who are diagnosed with prostate cancer.
Additional locations may be listed on ClinicalTrials.gov for NCT03770351.
Locations matching your search criteria
United States
California
Orange
UC Irvine Health/Chao Family Comprehensive Cancer CenterStatus: Active
Contact: Edward M. Uchio
Phone: 714-456-6717
PRIMARY OBJECTIVES:
I. Replicate/validate the risk prediction model developed for the CEASAR study in a more diverse patient population to assess generalizability of the model, comparing patients who receive radical prostatectomy, radiation therapy, or active surveillance for their prostate cancer.
II. Evaluate the impact of adding established genomic classifiers to the prediction model for outcomes within treatment group in a sample of patients within California.
OUTLINE:
Patients complete questionnaires at baseline, 6 months, and 12 months on study. Patients also undergo collection of tumor tissue and saliva samples.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUC Irvine Health/Chao Family Comprehensive Cancer Center
Principal InvestigatorEdward M. Uchio
